Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Tarsus Pharmaceuticals (TARS) Acquires iRenix Medical for $75M - GuruFocus

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

BofA lowers its Price Target on Madrigal Pharmaceuticals, Inc. (MDGL) - Insider Monkey

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Is Madrigal Pharmaceuticals (MDGL) Undervalued On Its New siRNA Milestone? - simplywall.st

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Tarsus Pharmaceuticals acquires iRenix for $75 million upfront - Investing.com

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

FAQ: Where US Pharma Reshoring Stands in 2026 - Pharmaceutical Commerce

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity - Yahoo Finance UK

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

AI as Reinvention | PharmExec - Pharmaceutical Executive

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Vertex Pharmaceuticals (VRTX) Buys Crinetics, Where Does Fair Value Sit Now? - Yahoo! Finance Canada

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength? - Yahoo Finance Singapore

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy - Yahoo Finance Australia

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Tarsus Pharmaceuticals Acquires iRenix With $37.5M Cash, Stock; Milestones Up to $490M - TradingView

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX - Business Wire

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Pangea Pharmaceuticals Advances Its Next Phase of Growth With an Expanding Commercial Portfolio - BioSpace

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026? - The Motley Fool

news.google.com · 09 Jul 2026

Google News – Pharmaceuticals External News

JPMorgan Ceases to Be Substantial Holder in Clarity Pharmaceuticals - TipRanks

news.google.com · 09 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Tarsus Pharmaceuticals (TARS) Acquires iRenix Medical for $75M - GuruFocus

BofA lowers its Price Target on Madrigal Pharmaceuticals, Inc. (MDGL) - Insider Monkey

Is Madrigal Pharmaceuticals (MDGL) Undervalued On Its New siRNA Milestone? - simplywall.st

Tarsus Pharmaceuticals acquires iRenix for $75 million upfront - Investing.com

FAQ: Where US Pharma Reshoring Stands in 2026 - Pharmaceutical Commerce

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity - Yahoo Finance UK

AI as Reinvention | PharmExec - Pharmaceutical Executive

Vertex Pharmaceuticals (VRTX) Buys Crinetics, Where Does Fair Value Sit Now? - Yahoo! Finance Canada

Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength? - Yahoo Finance Singapore

All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy - Yahoo Finance Australia

Tarsus Pharmaceuticals Acquires iRenix With $37.5M Cash, Stock; Milestones Up to $490M - TradingView

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX - Business Wire

Pangea Pharmaceuticals Advances Its Next Phase of Growth With an Expanding Commercial Portfolio - BioSpace

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026? - The Motley Fool

JPMorgan Ceases to Be Substantial Holder in Clarity Pharmaceuticals - TipRanks